Eikon Therapeutics announced that Leon Chen and Joshua Wolfe resigned from its Board of Directors effective July 31, 2026. The company stated that their departures were not due to any disagreements regarding operations, policies, or practices. Eikon Therapeutics operates in the biotechnology industry, focusing on drug discovery.
